β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals

Published:2019-01 Issue: Volume:7 Page:21-26
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Nielsen Anne Orholm,Pedersen Lars,Sode Birgitte Fischer,Dahl Morten

Funder

Danish Council for Independent Research

Research Foundation of Health Science in Region Zealand

Research Foundation of Medical Science (A.P. Møller Foundation)

Research Foundation in memory of King Christian 10th

Aase & Ejnar Danielsen's Research Foundation

Lundbeck Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease;McDonough;N Engl J Med,2011

2. A pathologist's view of airway obstruction in chronic obstructive pulmonary disease;Hogg;Am J Respir Crit Care Med,2012

3. Pharmacology;Rang,2003

4. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response;Nielsen;COPD,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COPD and multimorbidity: recognising and addressing a syndemic occurrence;The Lancet Respiratory Medicine;2023-11

2. Are beta-blockers safe and effective after myocardial infarction in patients with COPD?;JAAPA;2023-03

3. Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences;Therapeutic Advances in Chronic Disease;2023-01

4. Comprehensive care for people living with heart failure and chronic obstructive pulmonary disease—Integration of palliative care with disease-specific care: From guidelines to practice;Frontiers in Cardiovascular Medicine;2022-09-27

5. Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease;Kardiologiia;2021-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3